MarketInOut Stock Screener Log In | Sign Up
 

Bio-Techne Corp

NASDAQ • Healthcare • Biotechnology • Quote as of 08/14/2026
Bio-Techne Corp stock price and volume chart

Company Profile

IndustryBiotechnology
SectorHealthcare
ExchangeNASDAQ
Market Capitalization11,246 mln
Float155 mln
Earnings Date11/03/2026

EPS

1.16
Stretched

P / E

62.41
Richly valued

Piotroski F-Score

8 / 9
Very strong

Beneish M-Score

-2.57
Likely reliable

1-Year Forecast

69.73
Fairly priced

Relative Strength

32 / 100
Underperforming

Business Description

Founded in 1976 and based in Minneapolis, Minnesota, Bio-Techne develops and sells a broad range of tools and materials that support scientific research, medical testing, and the production of advanced therapies. Its products include proteins, antibodies, and laboratory instruments used by researchers and clinicians to study and measure biological activity. The company also produces diagnostic testing products and tissue analysis tools that help identify genetic conditions and cancer. Bio-Techne serves customers across the globe through two main business areas covering protein science and diagnostics.

Key Fundamentals

EPS1.16
P/E62.41
ROE9.01
RPS7.74
ROIC8.45
ROA7.14
Interest Cover33.55
EBITDA, mln351
EV / EBITDA32.12
EV / EBIT44.45
Revenue, mln1,215
EV / Revenue9.28

Financial Strength

Altman Z-Score15.17
Piotroski F-Score 8 / 9
Beneish M-Score-2.57
Price to Intrinsic Value2.76
Price to Graham Number4.97
1-Year Target Price69.73
Shiller PE Ratio58.72
Short Ratio1.80
Short % of Float6.80

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week 0.15% 45 / 100   
1 Month 0.88% 47 / 100   
2 Months 42.46% 95 / 100   
6 Months 21.99% 81 / 100   
1 Year 33.14% 78 / 100   



Disclaimer - Privacy Policy - Terms Of Service - Cookie Use Policy - FAQ - Contact Us